Vanderbilt joins global consortium to fight tuberculosis
Vanderbilt University Medical Center is participating in an international consortium to improve treatment of, and hopefully eliminate the scourge of, tuberculosis.
Tuberculosis is one of the world's most persistent and deadly diseases.
It kills 2 million people a year. Two billion people — one third of the world's population — are infected with the TB bacterium.
The Tuberculosis Trials Consortium recently received renewal funding from the U.S. Centers for Disease Control and Prevention (CDC). Its goal is to shorten the duration of treatment of tuberculosis among people with active disease who can spread it to others and among those with “latent” infection, to prevent them from developing TB disease.
Previous:
Lan Zhang joins VIGH
